Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients

The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings

(2013) David B. Rein et al.   ANNALS OF INTERNAL MEDICINE

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

(2011) Marc G. Ghany et al.   HEPATOLOGY

Hepatitis C virus infection in USA: an estimate of true prevalence

(2011) Eric Chak et al.   LIVER INTERNATIONAL

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Directly acting antivirals for hepatitis C and antiretrovirals

(2011) Kay Seden et al.   Current Opinion in HIV and AIDS

The global burden of hepatitis C

(2009) Daniel Lavanchy   LIVER INTERNATIONAL

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

(2009) John G. McHutchison et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY